665 related articles for article (PubMed ID: 16816005)
21. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
[TBL] [Abstract][Full Text] [Related]
23. Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.
Azofra MM; Somovilla JL; Porras MC; Carrillo LH; Pérez RD
Clin Infect Dis; 2010 Jul; 51(2):255-7. PubMed ID: 20560740
[No Abstract] [Full Text] [Related]
24. [Primary cutaneous aspergillosis in a leukemic child].
Torrelo A; Hernández-Martín A; Scaglione C; Madero L; Colmenero I; Zambrano A
Actas Dermosifiliogr; 2007 May; 98(4):276-8. PubMed ID: 17506961
[TBL] [Abstract][Full Text] [Related]
25. Fungal infections in bone marrow transplant recipients.
Raman T; Marik PE
Expert Opin Pharmacother; 2006 Feb; 7(3):307-15. PubMed ID: 16448325
[TBL] [Abstract][Full Text] [Related]
26. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
[TBL] [Abstract][Full Text] [Related]
27. Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Herbrecht R
Ann Hematol; 2002; 81 Suppl 2():S52-3. PubMed ID: 12611078
[No Abstract] [Full Text] [Related]
28. Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
Luque P; García-Gil FA; Larraga J; Jiménez B; Tomé-Zelaya E; Serrano MT; Barrao ME
Transplant Proc; 2006 Oct; 38(8):2514-5. PubMed ID: 17097985
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
Catalano L; Fontana R; Scarpato N; Picardi M; Rocco S; Rotoli B
Haematologica; 1997; 82(1):71-2. PubMed ID: 9107088
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
Sterba J; Prochazka J; Ventruba J; Kren L; Valik D; Burgetova D; Mudry P; Skotakova J; Blatny J
Pediatr Hematol Oncol; 2005 Dec; 22(8):649-55. PubMed ID: 16251170
[TBL] [Abstract][Full Text] [Related]
31. [Cardiac invasive aspergillosis in a heart transplant recipient].
Eworo A; Muñoz P; Yáñez JF; Palomo J; Guembe P; Roda J; Valerio M; Guinea J; Bouza E
Rev Iberoam Micol; 2011; 28(3):134-8. PubMed ID: 21700234
[TBL] [Abstract][Full Text] [Related]
32. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole versus amphotericin B for invasive aspergillosis.
Karthaus M
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
[No Abstract] [Full Text] [Related]
34. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
35. Voriconazole versus amphotericin B for invasive aspergillosis.
Blot F; Edé C; Nitenberg GM
N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12490695
[No Abstract] [Full Text] [Related]
36. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Chow L; Brown NE; Kunimoto D
Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
[TBL] [Abstract][Full Text] [Related]
37. Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
Tunçcan ÖG; Aki ŞZ; Akyürek N; Sucak G; Şenol E
J Infect Dev Ctries; 2011 May; 5(5):406-9. PubMed ID: 21628821
[TBL] [Abstract][Full Text] [Related]
38. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
39. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation.
Nenoff P; Kliem C; Mittag M; Horn LC; Niederwieser D; Haustein UF
Eur J Dermatol; 2002; 12(1):93-8. PubMed ID: 11809609
[TBL] [Abstract][Full Text] [Related]
40. Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
Wenzel R; Del Favero A; Kibbler C; Rogers T; Rotstein C; Mauskopf J; Morris S; Schlamm H; Troke P; Marciniak A
J Antimicrob Chemother; 2005 Mar; 55(3):352-61. PubMed ID: 15728146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
